Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.47 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31485403 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL62053 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL4638950 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL905579 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL418811 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL60425 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL60847 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL2695073 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL632448 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR | |
| SCHEMBL2693658 | 1.00 | SMPD1 (0.47) | SMPD1SLC25A20TP53CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3220 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | NOVOCURE GMBH (CH) | 2026-04-07 | — | — | US | claimed |
| US-20250339680-A1 | COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2025-11-06 | — | — | US | claimed |
| CN-119454909-B | Formulation composition of glucagon-like peptide-1 receptor agonist for nasal mucosa administration, preparation method, application and nasal applicator | 上海世领制药有限公司 | 2025-04-08 | — | — | CN | claimed |
| US-20250090558-A1 | APPLICATION OF MILTEFOSINE IN PROMOTING BONE FORMATION AND PREVENTING-TREATING OSTEOPOROSIS | The First Affiliated Hospital of Zhejiang Chinese Medical University (CN) | 2025-03-20 | — | — | US | claimed |
| CN-119454909-A | Formulation composition of glucagon-like peptide-1 receptor agonist for nasal mucosa administration, preparation method, application and nasal applicator | 上海世领制药有限公司 | 2025-02-18 | — | — | CN | claimed |
| EP-3586142-B1 | DETECTION OF MEMBRANE PROTEINS | UNIV OXFORD INNOVATION LTD (GB) | 2024-12-25 | — | — | EP | claimed |
| EP-4363043-A1 | COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | Novocure GmbH (CH) | 2024-05-08 | — | — | EP | claimed |
| CN-117580614-A | Compositions and methods for increasing sensitivity of cancer cells to alternating electric fields | 诺沃库勒有限责任公司 | 2024-02-20 | — | — | CN | claimed |
| US-11819508-B2 | Miltefosine for the treatment of viral infections including covid-19 | PROFOUNDA HEALTH AND BEAUTY INC. (US) | 2023-11-21 | — | — | US | claimed |
| EP-0393575-B1 | Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent | SEARLE & CO (US) | 1994-03-16 | — | — | EP | claimed |
| US-5290769-A | Applying compositions for skin disorders | ASTA PHARMA AKTIENGESELLSCHAFT (DE) | 1994-03-01 | — | — | US | claimed |
| EP-0359981-B1 | PHARMACEUTICAL COMBINATIONS AND THEIR USE AS ANTINEOPLASTIC MEDICINES | Roche Diagnostics GmbH (DE) | 1993-07-28 | — | — | EP | claimed |
| US-5049552-A | Anticancer agents | MAX-PLANCK-GESELLSCHAFT FUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 1991-09-17 | — | — | US | claimed |
| EP-0248047-B1 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1991-06-19 | — | — | EP | claimed |
| EP-0393575-A1 | Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent | G.D. Searle & Co. (US) | 1990-10-24 | — | — | EP | claimed |
| US-4837023-A | ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS | MAX-PLANCK-GESELLSCHAFT ZUR FOEDERUNG DER WISSENSCHAFTEN (DE) | 1989-06-06 | — | — | US | claimed |
| EP-0248047-A1 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE. | MAX PLANCK GESELLSCHAFT (DE) | 1987-12-09 | — | — | EP | claimed |
| EP-0230575-A2 | Medicament active against tumours, containing hexadecylphosphocholine | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1987-08-05 | — | — | EP | claimed |
| WO-1987003480-A2 | MEDICAMENT WITH ANTI-TUMORAL ACTION CONTAINING HEXADECYLPHOSPHOCHOLINE | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSC (DE) | 1987-06-18 | — | — | WO | claimed |